• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

docj

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 851-900 of 5665 result(s).

Board Name	Posts By docj	Post Created
GNBTQ Generex Biotechnology Corp.	GNBT NT http://archive.fast-edgar.c	11/01/2021 5:10:07 PM
GNBTQ Generex Biotechnology Corp.	NGIO NT http://archive.fast-edgar.c	11/01/2021 5:08:16 PM
GNBTQ Generex Biotechnology Corp.	So how do we explain the news flow (2)	11/01/2021 12:48:22 PM
CYDY CytoDyn Inc	Thanks!	11/01/2021 10:51:43 AM
GNBTQ Generex Biotechnology Corp.	The IND being filed is speculation. (3)	11/01/2021 10:15:09 AM
GNBTQ Generex Biotechnology Corp.	Does Generex realize we are in Nove (2)	11/01/2021 9:43:26 AM
CYDY CytoDyn Inc	Are we not expecting at least one B	11/01/2021 8:39:38 AM
CYDY CytoDyn Inc	Good question. I have followed the (6)	11/01/2021 7:53:58 AM
GNBTQ Generex Biotechnology Corp.	In most businesses it is considered (5)	10/31/2021 6:03:18 PM
GNBTQ Generex Biotechnology Corp.	That is because you are not a long (3)	10/29/2021 4:43:00 PM
GNBTQ Generex Biotechnology Corp.	That is true. I and a couple others	10/29/2021 4:35:42 PM
GNBTQ Generex Biotechnology Corp.	Since you are no longer a sharehold (10)	10/29/2021 3:13:27 PM
GNBTQ Generex Biotechnology Corp.	Re: the quiet period Earlier this w (1)	10/29/2021 2:31:38 PM
CYDY CytoDyn Inc	Sent an email to Drs Pourhassan and (2)	10/29/2021 1:14:53 PM
GNBTQ Generex Biotechnology Corp.	I think he was making a general sta	10/29/2021 10:57:14 AM
CYDY CytoDyn Inc	Anyone got price and volume info fr (1)	10/29/2021 8:35:43 AM
GNBTQ Generex Biotechnology Corp.	Think of all the time the team has (3)	10/29/2021 7:51:16 AM
CYDY CytoDyn Inc	I have one family member who did no (1)	10/28/2021 12:53:06 PM
CYDY CytoDyn Inc	I'd prefer to see the FDA document (5)	10/28/2021 7:03:43 AM
GNBTQ Generex Biotechnology Corp.	Funny to kid about but his shares d (5)	10/27/2021 9:31:13 PM
GNBTQ Generex Biotechnology Corp.	None of my emails have been kicked (2)	10/27/2021 2:48:59 PM
CYDY CytoDyn Inc	Some just cannot appreciate dealing (6)	10/27/2021 10:22:42 AM
CYDY CytoDyn Inc	Of course. You don't give them perm (2)	10/27/2021 9:52:40 AM
GNBTQ Generex Biotechnology Corp.	Well written as usual. I appreciate (1)	10/27/2021 2:11:39 AM
GNBTQ Generex Biotechnology Corp.	I am sure most saw the news about P (2)	10/26/2021 7:56:16 PM
GNBTQ Generex Biotechnology Corp.	If I recall right, Joe made that st (2)	10/26/2021 6:48:45 PM
CYDY CytoDyn Inc	I got this just now Re: long hauler (16)	10/26/2021 4:15:05 PM
GNBTQ Generex Biotechnology Corp.	There would have be a beneficial ow (2)	10/26/2021 11:14:00 AM
GNBTQ Generex Biotechnology Corp.	Just a reminder this is a long inve (7)	10/25/2021 5:30:11 PM
GNBTQ Generex Biotechnology Corp.	Hey rjs, did you send that to Joe? (3)	10/25/2021 11:50:42 AM
GNBTQ Generex Biotechnology Corp.	No problem. Let me know when I need (3)	10/22/2021 1:24:52 PM
GNBTQ Generex Biotechnology Corp.	Did I send you some moonshine by mi (3)	10/22/2021 12:58:16 PM
GNBTQ Generex Biotechnology Corp.	Have a great weekend Zolis_onkel. M (2)	10/22/2021 11:49:25 AM
CYDY CytoDyn Inc	"Personally, I would love to see hi (5)	10/22/2021 10:57:00 AM
GNBTQ Generex Biotechnology Corp.	This place seems popular with the w (2)	10/22/2021 10:45:45 AM
CYDY CytoDyn Inc	Hence part of the reason I withheld (7)	10/22/2021 7:54:16 AM
GNBTQ Generex Biotechnology Corp.	So, obvious point/question, yet I j (4)	10/22/2021 6:55:53 AM
GNBTQ Generex Biotechnology Corp.	You are probably right. I am surpri (6)	10/21/2021 6:49:05 AM
CYDY CytoDyn Inc	CytoDyn to Hold Webcast and Live Q/ (4)	10/21/2021 6:13:38 AM
CYDY CytoDyn Inc	CytoDyn Announces Delaware Court Ha (2)	10/20/2021 4:27:58 PM
CYDY CytoDyn Inc	Form 4's out	10/20/2021 4:12:58 PM
GNBTQ Generex Biotechnology Corp.	As we move through October it appea (2)	10/20/2021 7:44:33 AM
CYDY CytoDyn Inc	I voted for everything but I did wi (14)	10/20/2021 7:30:02 AM
GNBTQ Generex Biotechnology Corp.	I think I recall November being the (2)	10/20/2021 7:07:40 AM
CYDY CytoDyn Inc	I rec'd my proxy earlier this AM vi (2)	10/20/2021 7:04:55 AM
GNBTQ Generex Biotechnology Corp.	We have a new social media post and (4)	10/19/2021 6:16:01 PM
GNBTQ Generex Biotechnology Corp.	Todd informed me the the salary.com	10/15/2021 4:50:50 PM
GNBTQ Generex Biotechnology Corp.	Good to know you guys chatted. It w (4)	10/15/2021 12:38:56 PM
GNBTQ Generex Biotechnology Corp.	That pic is from December. More imp	10/14/2021 12:16:25 PM
GNBTQ Generex Biotechnology Corp.	Save yourself some time and go to t (1)	10/14/2021 12:11:35 PM

• Next >

62749606274958627472862745606274495627446662743746274318627415962734506273447627337462733306273241627307262728836272856627222262716566271557627135362710556271013627070562706046270573627048062702236269746626944262682796268242626810562680246268014626782962677666266925626689662667666266755626602962660206266002626599962658586263644626344762626856262682

Recent Articles

• Brera Holdings Rebrands to Solmate, Shares Surge Noticeably
• California Labor Code Violations Lead to Lawsuit Against Aspen
• Bybit Teams Up with QNB and DMZ for Groundbreaking Digital Asset Integration
• AGM Group Holdings Inc. Experiences Remarkable Stock Surge
• Huawei Introduces Next-Gen AI-Driven Network Solutions for Industries
• Google's Chrome Embraces Gemini AI, Ushering In a New Age
• Fluor Corporation Faces Legal Challenges Amid Analyst Concerns
• SEC Chair's Perspective on Crypto: Hype and Risks Unveiled
• Performance Insights: Intel, FedEx, Lennar, Brera, and Rivian
• Elevate Your Concrete Experience with Trice Contracting
• Strategic Leadership Expansion at Travel Answers Group
• Discover Why Trice Contracting is the Best Choice for Concrete
• Tesla and Samsung Forge Strategic Alliance for Chip Production
• Tesla and Samsung Forge Strategic Chip Partnership for Future
• Grvt Secures $19 Million to Redefine Onchain Financial Privacy
• Intel and Nvidia Unite: A Bold Move for AI and Computing Futures
• Job Market Outlook: Navigating AI Challenges for Graduates
• Cryptocurrency Market Adjusts Amid New SEC Guidelines
• ARK Invest's Bold Moves in Brera Holdings and Beyond
• IASO Bio Unveils Groundbreaking CAR-T Therapy Insights
• Secure Your Stake: Altimmune Class Action Deadline Approaches
• Investors Urged to Act in Charter Communications Class Action
• HIKSEMI Highlights Innovations in Smart Storage Solutions
• Reviva Pharmaceuticals Secures $9 Million in Public Offering
• Toronto Embraces Culinary Excellence with Michelin Stars in 2025
• AvePoint Expands Horizons with Singapore Exchange Listing
• How Flock Safety Plans to Eradicate Crime Using AI Technology
• Celebrate Connection: Transforming Gifting with Gratitude
• Innovations and Trends at the Upcoming Manufacturing Convention
• North Coast Brewing Company Celebrates European Beer Star Win
• Lawsuit Claims Sable Offshore Misled Investors on Oil Production
• Lockheed Martin Faces Class Action as Investors Seek Justice
• SelectQuote's Legal Challenges and Impact on Investors
• AusperBio Reaches Key Milestone in Hepatitis B Trials
• Huawei Innovations in Data Centers for AI-Powered Future
• Xplor Technologies Expands Payment Solutions with Ezypay Deal
• Canton Fair's Global Roadshow Sparks International Trade Growth
• Discover Interxsoft's Innovations at PCB West 2025 Event
• Perseus Mining's New Underground Operation at Yaouré Approved
• Celebrating Community Spirit at Halsey Fest 2025 Experience
• The Remarkable 5-Year Growth of Krystal Biotech's Stock Value
• Investigating Legal Rights of RCI Hospitality Holdings Investors
• GoPro Achieves Third Emmy Win for Outstanding 360 Technology
• Grupo Aeroportuario del Pacífico Secures New Credit Line Deal
• Investing in Linde Stocks: A Decade of Growth and Returns
• Exciting New Developments in Housing Announcement Event
• NGEx Minerals Limited Obtains Approval for Royalty Spin-Off
• P2 Gold Secures Funding Through Initial Private Placement Tranche
• IEHP's Legal Counsel Addresses Recent DOJ Lawsuit Challenges
• Jameson Irish Whiskey Reveals Exciting Plans for Football Fans